News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 325–360
- Matches
- 24574
- Sources here
- 14
- Companies here
- 42
Active search
24574 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Cactus, Inc. (WHD) Is Up 7.92% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …
Starship Delays Drive SpaceX Stock Lower
SpaceX stock was lower on Thursday. Shares have been volatile since the record-setting June IPO, but this drop likely stems from a Starship disappointment. Starship is SpaceX’s huge, fully reusable rocket designed to dramatically cut costs to reach orbit. Continue Reading
Prevail Bank Selects Jack Henry & Associates, Inc. to Differentiate Through Open Ecosystem and Ai Innovation
Prevail Bank has chosen Jack Henry & Associates, Inc.'s core processing platform and integrated solutions, including the Banno Digital Platform, Tap2Local, and Enterprise Workflow. This decision aims to enhance digital banking experiences, streamline operations, and bolster fraud detection. Jack Henry's open ecosystem and AI …
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Down 6.3% - What's Next?
ARS Pharmaceuticals (NASDAQ:SPRY) shares dropped 6.3% to $5.98 on unusually light trading volume. Despite missing quarterly EPS estimates with a loss of $0.63 per share, the company's revenue of $33.66 million exceeded forecasts, and analysts maintain a "Moderate Buy" rating with an average price …
Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN)
Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN) As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at therapeutics stocks, starting with …
Sharemaestro market context Trend signal active 52 weeks +15.0%Interactive Brokers Group (IBKR) Delivers Exceptional Growth at Scale
Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Focused Growth Fund". A copy of the letter can be downloaded here. In the second quarter, the Baron Focused Growth Fund achieved a 13.26% gain, still trailing the Russell …
Sharemaestro market context Trend signal active 52 weeks +30.6% · Next-week setup negative 30.7%Park Aerospace (NYSE:PKE) Shares Gap Down - Here's What Happened
Park Aerospace (NYSE:PKE) shares gapped down by 1.5% at market open, trading at $35.36 after closing at $36.90. Despite this, analysts maintain a "Buy" rating with an average price target of $42.50. The company exceeded quarterly expectations with EPS of $0.17 and revenue of …
Insider Selling: Aflac (NYSE:AFL) Major Shareholder Sells 14,200 Shares of Stock
Aflac (NYSE:AFL) major shareholder Post Holdings Co. Ltd. Japan sold 14,200 shares of the company's stock for approximately $1.73 million on August 18th, reducing their ownership by 0.03%. This transaction was part of a pre-arranged Rule 10b5-1 trading plan. Aflac recently traded at $117.25, …
Accenture Stock Gains 26.7% in a Month: Here's What You Should Know
Accenture ACN stock has gained 26.7% in a month, outperforming the industry's 8.8% growth and the Zacks S&P 500 Composite's 3% return. 1-Month Share Price PerformanceZacks Investment Research Image Source: Zacks Investment Research Let us delve deeper into the factors that have contributed to …
Sharemaestro market context Price below Trend Line 52 weeks -36.5%MACOM (MTSI) Stock Could Trade At A Premium On Strong Q3 Results
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. MACOM Technology Solutions Holdings has delivered a very strong 5 year share price return, yet current valuation checks suggest the stock is trading …
Will Refining Business Strength Continue to Support Par Pacific?
Par Pacific Holdings Inc. (PARR) is expected to continue benefiting from a strong refining market, firm fuel demand, and tight global product inventories, despite a potential near-term impact from a Hawaii turnaround. Other refiners like Phillips 66 (PSX) and Valero Energy (VLO) are also …
Modine Manufacturing Company (MMF) Q1 2025 Earnings Report - Results, Call & Slides
Modine Manufacturing Company (MMF) announced its Q1 2025 earnings, reporting actual EPS of €0.90, beating the consensus of €0.75 by €0.15. The company's revenue reached €574.57M, surpassing the expected €550.29M and showing a 6.28% year-over-year growth. The earnings call and slide deck for this …
BlackBerry vs. Aptiv: Which Auto Tech Stock Is the Better Buy?
The automotive industry is witnessing a shift toward software-defined and increasingly autonomous vehicles. BlackBerry BB participates primarily through its QNX automotive operating systems, while Aptiv PLC APTV is a designer and manufacturer of vehicle components and a provider of electrical, electronic and safety technology …
Sharemaestro market context Trend signal active 52 weeks +117.3%SpaceX Stock Is Down 38% From Its High. Here's Where It Will Be by 2028.
Space Exploration Technologies (NASDAQ: SPCX), better known as SpaceX, has been a volatile stock since going public over two months ago. As of Wednesday afternoon, it was down by more than 38% from the all-time high of $225.64 per share it set a few …
Will Corvus’ Sharply Wider 2026 Losses Recast Its Risk‑Reward Profile for Investors (CRVS)?
Corvus Pharmaceuticals (CRVS) reported significantly wider losses in Q2 2026 and for the first half of the year, with a net loss of US$17.96 million in Q2 compared to US$8.00 million a year prior. This shift from net income to a substantial loss highlights …
Regeneron Secures FDA Approval for Rare Genetic Disorder Drug
Regeneron Pharmaceuticals, Inc. REGN announced that the FDA has approved Pasatru (garetosmab-grts) to reduce the formation of new heterotopic ossification (HO) lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare genetic disorder characterized by progressive formation of abnormal …
Sharemaestro market context Price above Trend Line 52 weeks +24.3% · Next-week setup negative 36.4%SpaceX stock slips as 319 million new shares come to market
SpaceX stock slipped and fell back to its IPO price as another share unlock hit the public float. Around 319 million shares held by early employees and investors become eligible to trade on Thursday, the Day 70 tranche in a staggered lockup that will …
Sharemaestro market context Stored weekly price path 10 weeks -13.0% · Next-week setup negative 35.2%